Wordt geladen...
Molecular Alterations of KIT Oncogene in Gliomas
Gliomas are the most common and devastating primary brain tumours. Despite therapeutic advances, the majority of gliomas do not respond either to chemo or radiotherapy. KIT, a class III receptor tyrosine kinase (RTK), is frequently involved in tumourigenic processes. Currently, KIT constitutes an at...
Bewaard in:
Gepubliceerd in: | Cell Oncol |
---|---|
Hoofdauteurs: | , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
IOS Press
2007
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4618227/ https://ncbi.nlm.nih.gov/pubmed/17726262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2007/926274 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|